240 related articles for article (PubMed ID: 31364081)
1. Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Polymyxins: Implications for Therapeutic Use.
Nation RL; Forrest A
Adv Exp Med Biol; 2019; 1145():219-249. PubMed ID: 31364081
[TBL] [Abstract][Full Text] [Related]
2. Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
Zavascki AP; Nation RL
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993859
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of Polymyxins in Animals.
Marchand S; Grégoire N; Couet W
Adv Exp Med Biol; 2019; 1145():89-103. PubMed ID: 31364073
[TBL] [Abstract][Full Text] [Related]
4. Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use.
Bergen PJ; Bulman ZP; Saju S; Bulitta JB; Landersdorfer C; Forrest A; Li J; Nation RL; Tsuji BT
Pharmacotherapy; 2015 Jan; 35(1):34-42. PubMed ID: 25630411
[TBL] [Abstract][Full Text] [Related]
5. Bioanalysis and Stability of Polymyxins.
Milne RW
Adv Exp Med Biol; 2019; 1145():73-87. PubMed ID: 31364072
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
Tran TB; Velkov T; Nation RL; Forrest A; Tsuji BT; Bergen PJ; Li J
Int J Antimicrob Agents; 2016 Dec; 48(6):592-597. PubMed ID: 27793510
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?
Bergen PJ; Landersdorfer CB; Zhang J; Zhao M; Lee HJ; Nation RL; Li J
Diagn Microbiol Infect Dis; 2012 Nov; 74(3):213-23. PubMed ID: 22959816
[TBL] [Abstract][Full Text] [Related]
8. Polymyxin B versus colistin: an update.
Cai Y; Lee W; Kwa AL
Expert Rev Anti Infect Ther; 2015; 13(12):1481-97. PubMed ID: 26488563
[TBL] [Abstract][Full Text] [Related]
9. Colistin and polymyxin B: peas in a pod, or chalk and cheese?
Nation RL; Velkov T; Li J
Clin Infect Dis; 2014 Jul; 59(1):88-94. PubMed ID: 24700659
[TBL] [Abstract][Full Text] [Related]
10. An update on the arsenal for multidrug-resistant Acinetobacter infections: polymyxin antibiotics.
Kassamali Z; Jain R; Danziger LH
Int J Infect Dis; 2015 Jan; 30():125-32. PubMed ID: 25461655
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of the Individual Major Components of Polymyxin B and Colistin in Rats.
Sivanesan S; Roberts K; Wang J; Chea SE; Thompson PE; Li J; Nation RL; Velkov T
J Nat Prod; 2017 Jan; 80(1):225-229. PubMed ID: 28080060
[TBL] [Abstract][Full Text] [Related]
12. Rational Combinations of Polymyxins with Other Antibiotics.
Bergen PJ; Smith NM; Bedard TB; Bulman ZP; Cha R; Tsuji BT
Adv Exp Med Biol; 2019; 1145():251-288. PubMed ID: 31364082
[TBL] [Abstract][Full Text] [Related]
13. In vitro Pharmacodynamics and PK/PD in Animals.
Lee W; Cai Y; Lim TP; Teo J; Chua SC; Kwa AL
Adv Exp Med Biol; 2019; 1145():105-116. PubMed ID: 31364074
[TBL] [Abstract][Full Text] [Related]
14. [Polymyxins - review with emphasis on nephrotoxicity].
Mendes CA; Burdmann EA
Rev Assoc Med Bras (1992); 2009; 55(6):752-9. PubMed ID: 20191233
[TBL] [Abstract][Full Text] [Related]
15. To B or not to B, that is the question: is it time to replace colistin with polymyxin B?
Kassamali Z; Danziger L
Pharmacotherapy; 2015 Jan; 35(1):17-21. PubMed ID: 25346395
[TBL] [Abstract][Full Text] [Related]
16. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus.
Nation RL; Li J; Cars O; Couet W; Dudley MN; Kaye KS; Mouton JW; Paterson DL; Tam VH; Theuretzbacher U; Tsuji BT; Turnidge JD
Lancet Infect Dis; 2015 Feb; 15(2):225-34. PubMed ID: 25459221
[TBL] [Abstract][Full Text] [Related]
17. Polymyxins for the treatment of extensively-drug-resistant Gram-negative bacteria: from pharmacokinetics to bedside.
Zavascki AP
Expert Rev Anti Infect Ther; 2014 May; 12(5):531-3. PubMed ID: 24666285
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.
Velkov T; Roberts KD; Nation RL; Thompson PE; Li J
Future Microbiol; 2013 Jun; 8(6):711-24. PubMed ID: 23701329
[TBL] [Abstract][Full Text] [Related]
19. Optimizing use of colistin and polymyxin B in the critically ill.
Nation RL; Li J
Semin Respir Crit Care Med; 2007 Dec; 28(6):604-14. PubMed ID: 18095224
[TBL] [Abstract][Full Text] [Related]
20. Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins.
Lu X; Chan T; Xu C; Zhu L; Zhou QT; Roberts KD; Chan HK; Li J; Zhou F
J Antimicrob Chemother; 2016 Feb; 71(2):403-12. PubMed ID: 26494147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
